Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared on Monday
We recently published a list of Why These 10 Firms Soared on Monday. In this article, we are going to take a look at where BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) stands against other Monday's best performers.
The stock market kicked off the trading week on a negative note as investors sold off on a new round of uncertainties from President Donald Trump's tariff policies.
The Nasdaq fell by 0.74 percent, while the S&P 500 dropped 0.64 percent and the Dow Jones was down by 0.24 percent.
Over the weekend, Trump told reporters that the US was negotiating with many countries, 'but at the end of this, I'll set my own deals — because I set the deal, they don't set the deal.'
He added that he had no intentions to talk with Chinese President Xi Jinping, dampening hopes of a potential negotiation between the two of the world's largest economies.
Beyond the major indices, 10 companies stood out with strong gains amid a flurry of fresh developments. In this article, we name Monday's 10 best performers and detail the reasons behind their gains.
To come up with the list, we considered only the stocks with a $2-billion market capitalization and $5-million trading volume.
Why BioCryst Pharmaceuticals, Inc. (BCRX) Soared on Monday
A scientist in a lab coat observing a line of medicine pills in a container.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX)
BioCryst Pharmaceuticals jumped by 23.52 percent on Monday, a second straight day, ending the day at $11.03 apiece following its impressive earnings performance in the first quarter, coupled with a highly optimistic outlook for the rest of the year.
In a statement, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) said it swung to a net income of $32,000 from a net loss of $35.38 million in the same period a year earlier as revenues jumped by 57 percent to $145.5 million from $92.76 million year-on-year, thanks to the strong performance of its hereditary angioedema treatment, Orladeyo.
Looking ahead, BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) said it now expects to be fully profitable for the rest of the year ahead of its original target.
Revenues from Orladeyo alone were expected to settle between $580 million and $600 million, higher than the $535 million to $550 million targeted previously.
Full-year operating expenses were also targeted to settle only between $440 million and $450 million, from the previous $425 million to $435 million.
Overall, BCRX ranks 2nd on our list of Monday's best performers. While we acknowledge the potential of BCRX as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than BCRX but that trades at less than 5 times its earnings, check out our report about this cheapest AI stock.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Axios
11 minutes ago
- Axios
Threats to Tesla's revenue are piling up
Tesla faces fresh risks to a big income stream: sales of regulatory credits to other automakers under vehicle emissions and efficiency rules. Why it matters: Tesla's credit sales were $595 million last quarter and totaled $3.36 billion in the five quarters through Q1 of 2025. The credits are awarded to companies like Tesla that exceed emissions standards. Producers of gas-powered vehicles buy them to help meet various CO2 and mileage standards. The latest: Republicans on the Senate's commerce committee late last week proposed ending civil penalties under the Transportation Department's fuel economy rules. It's part of the committee's portion of the budget "reconciliation" bill — the top GOP and White House legislative priority. The provision would "modestly" cut auto prices by ending penalties on automakers that now "design cars to conform to the wishes of DC bureaucrats rather than consumers," a GOP summary states. The intrigue:"This Senate action would effectively end the market for CAFE credits," Chris Harto, a senior policy analyst at Consumer Reports, tells Axios via email. Dan Becker, who heads the Safe Climate Transport Campaign at the Center for Biological Diversity, noted: "Why buy credits if Trump gives you a get out of CAFE free card?" Driving the news: Separately, DOT on Friday issued an "interpretive rule" that bars consideration of EVs when it sets these mileage rules. It's a step toward crafting replacement standards, DOT said. This paves the way for less aggressive requirements — and less need for buying credits. State of play: Several buckets of credits benefit Tesla, the dominant U.S. EV seller. EPA emissions standards, Transportation Department fuel economy mandates, and California's ambitious clean cars program all provide opportunities. European emissions rules also generate credits. The big picture: The regulatory credit market was already facing risks before all the news late last week. EPA is planning to rescind Biden-era EPA carbon emissions rules for model years 2027 and onward. The House-passed reconciliation bill and the Senate GOP proposal would also nix them. And the House bill pulls back Biden-era DOT mileage rules. Both chambers have passed measures that end EPA's approval of California's auto emissions rules. Threat level: Potential loss of credit revenues comes at a perilous time for Tesla. Its sales have slumped in recent quarters, and CEO Elon Musk's rightward turn and alliance with Trump are among the reasons why, analysts say. The House plan ends $7,500 consumer purchase subsidies for EVs under the Democrats' 2022 Inflation Reduction Act. By the numbers: Credit revenues exceeded Tesla's overall profit last quarter — in other words, it would have been in the red without them. Yes, Q1 was atypically weak for Tesla, but consider Q4 of 2024, when Tesla reported $2.13 billion in profits that were helped along by $692 million in credit sales. In Q3, those numbers were $2.17B and $739M, respectively. Friction point: More broadly, the meltdown of Tesla CEO Elon Musk's relationship with Trump also creates new and unpredictable risks for the billionaire entrepreneur's business empire.
Yahoo
12 minutes ago
- Yahoo
U.S., Chinese delegates in London to talk trade, rare earths
June 9 (UPI) -- Delegates from the United States and China are set to meet Monday in London after a phone call between the nations' leaders seemingly led to a cooling of tensions related to their otherwise heated recent trade dispute. "We are a nation that champions free trade and have always been clear that a trade war is in nobody's interests, so we welcome these talks," said a British government spokesperson. The U.K. has provided the space for the countries to chat but hasn't publicly disclosed its location. American attendees are slated to include U.S. Commerce Secretary Howard Lutnick, U.S. Treasury Secretary Scott Bessent and U.S. Trade Representative Jamieson Greer, while Chinese Vice Premier He Lifeng will lead his country's delegation. It is expected the discussion will put a fair amount of focus on the rare earth minerals situation. The Trump administration had expected China to back down on export restrictions it had imposed in April on such minerals after talks held in May. China imposed those restrictions in response to tariffs levied by Trump on Chinese goods. The resulting trade disruption has led to a 2.9% decrease on exports to the United States from April to May, the decrease from May 2024 is 3.4% and the cumulative year-on-year decrease from January to May is at 4.9%, according to Chinese customs data. However President Donald Trump and Chinese President Xi Jinping spoke on the phone last week, and the conversation was reportedly so friendly it not only led to Monday's meeting but each invited the other to make a personal visit. American and Chinese representatives had met last month in Geneva and reportedly reached an agreement to suspend most of the tariffs that had been reciprocally imposed, but both countries have since been accused of agreement violations by the other.
Yahoo
12 minutes ago
- Yahoo
JD Vance says the ‘blood feud' between Trump and Musk is ‘not going to be good for Elon' but admits he ‘suffered a lot' for the White House
Vice President JD Vance acknowledged the deepening feud between Elon Musk and President Trump but emphasized his hope that Musk could eventually reconcile with the Trump administration, praising Musk's past efforts with DOGE and calling him a 'transformational entrepreneur.' While defending Trump and dismissing Musk's Epstein-related claims as baseless, Vance warned that Musk's aggressive political stance could backfire, both for his companies and the broader national interest. It's been pointed out by many spectators that the feud between the world's richest man, Elon Musk, and arguably the world's most powerful man, Donald Trump, is not going to end well for any involved. And JD Vance, Trump's political right hand, agrees. The Tesla CEO and president have fallen out to a major extent, at first over the White House's 'Big, Beautiful Bill', which Musk says will undo all the work of his Department of Government Efficiency (DOGE). But since Musk's departure from Washington D.C. several weeks ago, his attacks on President Trump have continued to ramp up. He has encouraged voters to outright rebel against the bill by contacting their political representatives, with Trump saying he was 'disappointed' in Musk for such statements. The man worth $342 billion hit back that Trump would have lost the election without his backing, with the president then threatening to terminate a host of government contracts to Musk's private entities. In response, Musk claimed that the president's name was in the Epstein files—a jibe he provided no evidence to support. Speaking in an interview this week, Vice President Vance said any notion that Trump did 'anything wrong with Jeffrey Epstein' is 'BS.' Yet while the relationship between the Musk and Trump seems to have gone past the point of no return, Vice President Vance says he still wants to see the SpaceX founder return to the fold of the Trump 2.0 team. 'My basic read on it, first of all I'm the vice president to President Trump, my loyalties are always going to be with the president. Elon [is] an incredible entrepreneur, I think DOGE was really good. The effort to root out waste, fraud and abuse in our country was really good,' Vance told the 'This Past Weekend' podcast with Theo Von. 'I hope that eventually Elon kind of comes back into the fold. Maybe that's not possible now because he's gone so nuclear—I hope it is,' Vance added. Musk's decision to go 'nuclear', as Vance describes it, may not prove to be in the best interest of his companies, such as Tesla and Space X, which may now draw the attention of the Oval Office for the wrong reasons. As a result of this concern, in the past five days alone the share price of Tesla has sunk more than 14%, with Musk's net worth taking an eye-watering hit as a result. Vance suggested that Musk may be shooting from the hip instead of assessing the ramifications of going head-to-head with the White House, adding: 'Elon's new to politics … I think part of it is this guy got into politics and has suffered a lot for it.' Indeed even prior to a spat with the White House, Musk was suffering for his political interests. While heading up DOGE, protestors to his work and the Trump administration began targeting Tesla by damaging cars, showrooms, and charging points—not only in the U.S. but also across Europe. 'The process in D.C., if you're a business leader you probably get frustrated with that process because it's more bureaucratic [and] slow moving. So I think there's some frustrations there,' Vance added. 'But I think it's huge mistake for [Musk] to go after the president like that. I think that if he and the president are in some blood feud, most importantly it's going to be bad for the country but I … don't think it's going to be good for Elon either.' Concerns have been raised about the bill on account of the fiscal ramifications of the largest tax breaks 'in history,' with previous projections from the Congressional Budget Office (CBO) finding the legislation would add $3.8 trillion to the deficit while proposed cuts to Medicaid would shave only $1 trillion in spending. However the Trump administration said statements such as 'The One Big Beautiful Bill increases spending' and 'The One Big Beautiful Bill adds to the deficit' are false. For example, the White House points to the CBO's predictions that while tariffs will shrink the economy it will also reduce federal deficits by $2.8 trillion (the inclusion of the Big Beautiful Bill in its modeling is not mentioned). 'I think that it's a good bill and it does a lot of good for the American people,' Vance continued. 'Look, Elon's entitled to his opinion. I'm not saying he has to agree with the bill or agree with everything that I'm saying, I just think it's a huge mistake for the world's wealthiest man—I think one of the most transformational entrepreneurs ever—to be at war with the world's most powerful man who I think is doing more to save the country than … anybody in my lifetime.' He added: 'I don't want to reveal too many confidences but [Trump] was getting a little frustrated, feeling like some of the criticisms were unfair coming from Elon … the president doesn't think that he needs to be in a blood feud with Elon Musk, and I actually think if Elon chilled out a little bit, everything would be fine.' This story was originally featured on
